News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
169 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17904)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (103)
2 (1)
4 (140)
5 (169)
6 (148)
7 (144)
8 (68)
9 (22)
10 (23)
11 (209)
12 (180)
13 (124)
14 (146)
15 (82)
17 (2)
18 (146)
19 (143)
20 (110)
21 (123)
22 (70)
24 (1)
25 (2)
26 (8)
27 (78)
28 (44)
29 (45)
30 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
30
Business
New England Biolabs and CasZyme Collaborate to Enable Genome Editing Applications With Novel Cas9 Enzymes
Under the terms of the agreement, CasZyme and NEB will apply their enzymology expertise to identify and characterize Cas nucleases.
December 5, 2017
·
3 min read
Success of mRNA Rabies Vaccine Human Study Linked to Needle-Free Injection
A key finding was that the use of needle-free injection demonstrated successful immunogenicity of the vaccine, while needle-syringe failed to induce an adequate antibody response.
December 5, 2017
·
2 min read
AYOXXA Launches LUNARIS Human 11-Plex Ophthalmology Kit
The assay is optimized for usage on LUNARIS, AYOXXA’s innovative multiplex protein analysis system.
December 5, 2017
·
7 min read
Lone Star Bio
CorInnova Awarded “2017 InnoSTARS” Prize for its Non-Blood-Contacting, Soft Robotic Heart Assist Device as Alternative to LVADs for Treatment of Heart Failure
The competition provided U.S.-based innovators and companies with a better understanding of the opportunities available to companies interested in doing business in China as well as well as direct interface with qualified Chinese partners and investors.
December 5, 2017
·
4 min read
Drug Development
Ovid Therapeutics Announces TAK-935/OV935 Has Received Orphan Drug Designation From U.S. FDA for Treatment of Dravet Syndrome
Takeda and Ovid formed a global collaboration to develop and commercialize TAK-935/OV935 for the treatment of developmental and epileptic encephalopathies in January 2017.
December 5, 2017
·
7 min read
Pharm Country
Illinois Hospital, Affiliated Imaging Centers Install Nine Carestream DR Systems to Deliver Rapid Image Access, Excellent Image Quality
The hospital and its affiliated outpatient and urgent care clinics began converting to digital radiography several years ago to achieve improved image quality, higher staff productivity and rapid image access for physicians.
December 5, 2017
·
4 min read
Business
Check-Cap Announces Advancement in GE Healthcare Manufacturing Collaboration
Check-Cap will supply GE with supporting calibration and final assembly methodology and equipment.
December 5, 2017
·
3 min read
Biotech Beach
Second Sight Announces Market Entry Into Iran With First Two Implants of Argus II Retinal Prosthesis System
Second Sight announced market entry into Iran, implanting the first two patients with the Company’s Argus II Retinal Prosthesis System (“Argus II”).
December 5, 2017
·
6 min read
CV Sciences Repays Installment Obligation on Convertible Debt
Company avoids dilution to stockholders.
December 5, 2017
·
2 min read
Previous
17 of 17